Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 01-Mar-06 9:53 PM View:  | ViroPharma Inc. (VPHM) | 28-Feb-06 | Market Sale | 111,194 | $20.07 | $2,231,500.00 | (5%) 2.07M to 1.96M | (150%) |
| 01-Mar-06 9:53 PM View: | ViroPharma Inc. (VPHM) | 27-Feb-06 | Market Sale | 112,218 | $21.72 | $2,437,150.00 | (5%) 2.18M to 2.07M | (131%) |
| 06-Oct-05 2:25 PM View: | Genomic Health Inc. (GHDX) | 04-Oct-05 | Conversion | 137,243 | -- | -- | 100% 0 to 137.24K | |
| 06-Oct-05 2:25 PM View: | Genomic Health Inc. (GHDX) | 04-Oct-05 | Acquisition (other) | 5,551 | -- | -- | 4% 137.24K to 142.79K | |
| 06-Oct-05 2:25 PM View: | Genomic Health Inc. (GHDX) | 04-Oct-05 | Market Purchase | 38,684 | $12.00 | $464,208.00 | 27% 142.79K to 181.48K | 616% |
| 19-Jul-05 4:42 PM View: | Ardea Biosciences, Inc. (RDEA) | 14-Jul-05 | Market Purchase | 39,516 | $3.50 | $138,306.00 | 10% 396.34K to 435.85K | 167% |
| 12-May-05 10:00 PM View: | ViroPharma Inc. (VPHM) | 10-May-05 | Market Purchase | 322 | $2.65 | $853.85 | 6% 5.41K to 5.74K | 1795% |
| 06-May-05 5:15 PM View: | Seattle Genetics Inc. (SGEN) | 04-May-05 | Market Purchase | 6,627 | $4.79 | $31,741.30 | 2% 346.52K to 353.15K | 1359% |
| 04-May-05 3:41 PM View: | Seattle Genetics Inc. (SGEN) | 29-Apr-05 | Market Purchase | 81,750 | $4.00 | $326,985.00 | 31% 264.77K to 346.52K | 1648% |
| 12-May-05 10:00 PM View: | ViroPharma Inc. (VPHM) | 28-Apr-05 | Market Purchase | 2,620 | $1.79 | $4,689.28 | 94% 2.79K to 5.41K | 2707% |
| 14-Apr-05 6:16 PM View: | Ardea Biosciences, Inc. (RDEA) | 12-Apr-05 | Market Purchase | 1,374 | $3.57 | $4,905.18 | < 1% 394.96K to 396.34K | 161% |
| 01-Apr-05 5:57 PM View: | Seattle Genetics Inc. (SGEN) | 30-Mar-05 | Market Purchase | 10,816 | $4.96 | $53,674.40 | 4% 253.96K to 264.77K | 1309% |
| 30-Mar-05 7:43 PM View: | Seattle Genetics Inc. (SGEN) | 29-Mar-05 | Market Purchase | 8,420 | $4.87 | $41,039.00 | 3% 245.54K to 253.96K | 1334% |
| 30-Mar-05 7:43 PM View: | Seattle Genetics Inc. (SGEN) | 28-Mar-05 | Market Purchase | 809 | $4.90 | $3,964.10 | < 1% 244.73K to 245.54K | 1327% |
| 24-Mar-05 6:37 PM View: | Seattle Genetics Inc. (SGEN) | 23-Mar-05 | Market Purchase | 71,278 | $4.96 | $353,505.00 | 41% 173.45K to 244.73K | 1309% |
| 24-Mar-05 6:37 PM View: | Seattle Genetics Inc. (SGEN) | 22-Mar-05 | Market Purchase | 79,401 | $5.03 | $399,094.00 | 84% 94.05K to 173.45K | 1291% |
| 14-Feb-05 9:19 PM View: | ViroPharma Inc. (VPHM) | 31-Jan-05 | Market Purchase | 193 | $3.02 | $582.74 | 100% 0 to 0.19K | 1564% |
| 02-Nov-04 9:22 PM View: | Neurogen Corp. (NRGN) | 13-Oct-04 | Disposition (other) | 268,465 | -- | -- | (12%) 2.31M to 2.04M | |
| 03-Nov-04 2:22 PM View: | Seattle Genetics Inc. (SGEN) | 13-Oct-04 | Disposition (other) | 13,542 | -- | -- | (13%) 107.59K to 94.05K | |
| 03-Nov-04 2:07 PM View: | Ardea Biosciences, Inc. (RDEA) | 13-Oct-04 | Disposition (other) | 48,266 | -- | -- | (11%) 437.3K to 389.03K | |
| 02-Nov-04 9:29 PM View: | Trimeris Inc. (GEVA) | 13-Oct-04 | Disposition (other) | 586,556 | -- | -- | (34%) 1.73M to 1.14M | |
| 14-Sep-04 10:00 PM View: | Trimeris Inc. (GEVA) | 14-Sep-04 | Market Purchase | 22,322 | $13.32 | $297,329.00 | 1% 1.71M to 1.73M | (10371%) |
| 14-Sep-04 10:00 PM View: | Trimeris Inc. (GEVA) | 13-Sep-04 | Market Purchase | 17,859 | $13.56 | $242,152.00 | 1% 1.69M to 1.71M | (10190%) |
| 14-Sep-04 10:00 PM View: | Trimeris Inc. (GEVA) | 10-Sep-04 | Market Purchase | 34,934 | $12.57 | $439,185.00 | 2% 1.66M to 1.69M | (10982%) |
| 12-Aug-04 7:22 PM View: | Seattle Genetics Inc. (SGEN) | 12-Aug-04 | Market Purchase | 28,031 | $5.58 | $156,365.00 | 35% 80.4K to 108.43K | 1153% |
| 12-Aug-04 7:22 PM View: | Seattle Genetics Inc. (SGEN) | 11-Aug-04 | Market Purchase | 5,416 | $5.43 | $29,416.10 | 7% 74.98K to 80.4K | 1187% |
| 12-Aug-04 7:22 PM View: | Seattle Genetics Inc. (SGEN) | 10-Aug-04 | Market Purchase | 12,298 | $5.32 | $65,399.50 | 20% 62.68K to 74.98K | 1214% |
| 09-Aug-04 10:00 PM View: | Seattle Genetics Inc. (SGEN) | 06-Aug-04 | Market Purchase | 4,409 | $5.50 | $24,249.50 | 8% 58.27K to 62.68K | 1171% |
| 09-Aug-04 10:00 PM View: | Seattle Genetics Inc. (SGEN) | 05-Aug-04 | Market Purchase | 17,480 | $5.54 | $96,860.20 | 43% 40.79K to 58.27K | 1161% |
| 04-Aug-04 10:00 PM View: | Seattle Genetics Inc. (SGEN) | 04-Aug-04 | Market Purchase | 16,557 | $5.58 | $92,368.20 | 68% 24.24K to 40.79K | 1153% |
| 04-Aug-04 10:00 PM View: | Seattle Genetics Inc. (SGEN) | 03-Aug-04 | Market Purchase | 13,665 | $5.71 | $78,057.20 | 129% 10.57K to 24.24K | 1124% |
| 04-Aug-04 10:00 PM View: | Seattle Genetics Inc. (SGEN) | 02-Aug-04 | Market Purchase | 10,571 | $5.97 | $63,105.60 | 100% 0 to 10.57K | 1071% |
| 07-May-04 10:00 PM View: | Ardea Biosciences, Inc. (RDEA) | 05-May-04 | Market Purchase | 221,996 | $13.00 | $2,885,950.00 | 106% 208.91K to 430.9K | (28%) |
| 21-Apr-04 10:00 PM View: | Neurogen Corp. (NRGN) | 19-Apr-04 | Private Purchase | 2,241,290 | $7.00 | $15,689,000.00 | 3377% 66.37K to 2.31M | |
| 17-Mar-04 10:00 PM View: | Ardea Biosciences, Inc. (RDEA) | 15-Mar-04 | Market Purchase | 8,877 | $16.11 | $143,040.00 | 4% 199.26K to 208.14K | (42%) |
| 08-Oct-03 10:00 PM View: | Ardea Biosciences, Inc. (RDEA) | 06-Oct-03 | Market Purchase | 172,050 | $10.80 | $1,858,140.00 | 744% 23.11K to 195.16K | (14%) |
| 30-Sep-03 10:00 PM View: | Trimeris Inc. (GEVA) | 26-Sep-03 | Market Purchase | 56,650 | $24.89 | $1,410,260.00 | 2% 3.2M to 3.26M | (5596%) |
| 24-Sep-03 10:00 PM View: | Incyte Corp (INCY) | 22-Sep-03 | Market Purchase | 71,100 | $4.97 | $353,399.00 | 3% 2.11M to 2.18M | 1349% |
| 23-Sep-03 10:00 PM View: | Incyte Corp (INCY) | 19-Sep-03 | Market Purchase | 556,350 | $5.04 | $2,802,560.00 | 120% 463.96K to 1.02M | 1330% |